Relationship between Absolute Lymphocyte Count and Ascites in Patients with Liver Cirrhosis
), Austin Bertilova Carmelita(2), Lia Sasmithae(3), Donna Novina Kahanjak(4), Ravenalla Abdurrahman Al Hakim Sampurna Putra S(5),
(1) Medical Study Program, Faculty of Medicine, Universitas Palangka Raya, Palangka Raya
(2) Department of Physiology, Faculty of Medicine, Universitas Palangka Raya, Palangka Raya
(3) Department of Internal Medicine, Faculty of Medicine, Universitas Palangka Raya, Palangka Raya
(4) Department of Physiology, Faculty of Medicine, Universitas Palangka Raya, Palangka Raya
(5) Department of Public Health, Faculty of Medicine, Universitas Palangka Raya, Palangka Raya
Corresponding Author
Abstract
Background: Cirrhosis is the final stage of liver disease characterized by fibrosis and irreversible nodule formation due to chronic inflammation. The most common liver cirrhosis complication is ascites, where pathological fluid accumulates in the peritoneal cavity. In cirrhosis, lymphocytes infiltrate the liver and contribute to stellate cell activation, differentiation, and the fibrogenic response. Many recent studies have not studied a relationship between the absolute lymphocyte count and ascites in liver cirrhosis. Therefore, it is important to investigate the relationship between lymphocytes and ascites in liver cirrhosis.
Method: This is an observational study with a cross-sectional design study. Held in August–October 2022 at Dr. Doris Sylvanus Hospital's Medical Record Installation. 64 samples were selected based on inclusion and exclusion criteria. Meanwhile, absolute lymphocyte count were measured from the patient's blood tests or by calculation. Ascites were diagnosed by physical examination and radiology. The relationship between absolute lymphocyte count and ascites was analyzed using the chi-square test, with the results considered statistically significant when the p-value < 0.05.
Result: The medical records from April 2019 to April 2022, there were 64 samples, of which 15 and 49 were without and with ascites. Based on the chi-square test results, there was a significant relationship between absolute lymphocyte count and the incidence of ascites, with p = 0.02.
Conclusion: This study concluded that there is a relationship between absolute lymphocyte count and ascites in patients with liver cirrhosis, where absolute lymphocyte count tends to decrease.
Keywords
References
Neong SF, Adebayo D, Wong F. An update on the pathogenesis
and clinical management of cirrhosis with refractory ascites.
Expert Rev Gastroenterol Hepatol 2019;13:293–305.
Garcia-Tsao G. Ascites. In: Dooley JS, Lok ASF, Garcia-
Tsao G, Pinzani M, eds. Sherlock’s Diseases of the Liver and
Biliary System. 13th ed. Chichester, UK: John Wiley & Sons,
Ltd 2018:XIII.p.127–50.
Maghfirah D, Azzaki A, Yusuf F. Penatalaksanaan asites pada
sirosis hepatis. J Ked N Med 2018;1:x.
Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of
liver diseases in the world. J Hepatol 2019;70:151–71.
Yong BJC, Vidor M. Sirosis hepatis - reversibel atau
irreversibel? Cermin Dunia Kedokteran 2022;49:43–6.
Roehlen N, Crouchet E, Baumert TF. Liver fibrosis:
mechanistic concepts and therapeutic perspectives. Cells
;9:875.
Hirlan. Asites. In: Buku Ajar Ilmu Penyakit Dalam. 6th ed.
Jakarta: Interna Publishing 2014:VI.p.x.
Romanelli RG, Vitiello G, Gitto S, Giudizi MG, Biagiotti R,
Carraresi A, et al. Characterization of lymphocyte subsets
in ascitic fluid and peripheral blood of decompensated
cirrhotic patients with chronic hepatitis C and alcoholic
liver disease: a pivotal study. Int J Immunopathol Pharmacol
;34:2058738420929587.
Li XK, Wu JP, Mao WL. Evaluation of the neutrophil-tolymphocyte
ratio, monocyte-to-lymphocyte ratio, and red cell
distribution width for the prediction of prognosis of patients
with hepatitis B virus-related decompensated cirrhosis. J Clin
Lab Anal 2020;34:e23478.
Vaz J, Eriksson B, Strömberg U, Buchebner D, Midlöv P.
Incidence, aetiology and related comorbidities of cirrhosis: a
Swedish population-based cohort study. BMC Gastroenterol
;20:84.
Sepanlou SG, Safiri S, Bisignano C, Ikuta KS, Merat S,
Saberifiroozi M, et al. The global, regional, and national
burden of cirrhosis by cause in 195 countries and territories,
–2017: a systematic analysis for the global burden of
disease study 2017. Lancet Gastroenterol Hepatol 2020;5:245–
Razavi H. Global epidemiology of viral hepatitis. Gastroenterol
Clin North Am 2020;49:179–89.
Wang H, Men P, Xiao Y, Gao P, Lv M, Yuan Q, et al. Hepatitis
B infection in the general population of China: a systematic
review and meta-analysis. BMC Infect Dis 2019;19:811.
Carrier P, Debette-Gratien M, Jacques J, Loustaud-Ratti
V. Cirrhotic patients and older people. World J Hepatol
;11:663–77.
Chiejina M, Kudaravalli P, Samant H. Ascites. In: StatPearls
[serial online]. Treasure Island (FL): StatPearls Publishing.
Available from: https://pubmed.ncbi.nlm.nih.
gov/29262009/.
Allen AM, Therneau TM, Ahmed OT, Gidener T, Mara KC,
Larson JJ, et al. Clinical course of non-alcoholic fatty liver
disease and the implications for clinical trial design. J Hepatol
;77:1237–45.
Gustot T, Stadlbauer V, Laleman W, Alessandria C, Thursz
M. Transition to decompensation and acute-on-chronic liver
failure: role of predisposing factors and precipitating events.
J Hepatol 2021;75:S36–48.
Bosch J, Berzigotti A. Portal hypertension in cirrhosis.
In: Dooley JS, Lok ASF, Garcia-Tsao G, Pinzani M, eds.
Sherlock’s Diseases of the Liver and Biliary System. 13th ed.
Chichester, UK: John Wiley & Sons, Ltd 2018:XIII.p.180–208.
Nababan SHH, Mansjoer A, Fauzi A, Gani RA. Predictive
scoring systems for in-hospital mortality due to acutely
decompensated liver cirrhosis in Indonesia. BMC Gastroenterol
;21:392.
Rubin JB, Sundaram V, Lai JC. Gender differences among
patients hospitalized with cirrhosis in the United States. J Clin
Gastroenterol 2020;54:83–9.
Griselda G, Rahadiyanto KY, Hidayat R. The relationships
between neutrophil/lymphocyte ratio and child-turcotte-pugh
classification in assessing severity of liver cirrhosis. J Biomed
Transl Res 2019;3:14–27.
Pravitasari RA. Correlation between ascites and total
lymphocyte count with occurrence of hepatic encephalopathy
in liver cirrhosis patients. Jurnal Kedokteran Brawijaya
;31:3.
Fitzgerald B, Kenzie WR, Rasmussen SA, Leahy MA,
Martinroe JC, Spriggs SR, et al. Morbidity and mortality
weekly report prevention of hepatitis B virus infection in the
United States: recommendations of the Advisory Committee
on Immunization Practices Recommendations and reports
Centers for Disease Control and Prevention MMWR editorial
and production staff (serials) MMWR editorial board. MMWR
Recomm Rep 2018;67:455–8.
Tanwar S, Rhodes F, Srivastava A, Trembling PM, Rosenberg
WM. Inflammation and fibrosis in chronic liver diseases
including nonalcoholic fatty liver disease and hepatitis C.
World J Gastroenterol 2020;26:109–33.
Sun R, Xiang Z, Wu B. T cells and liver fibrosis. Port
Hypertens Cirrhos 2022;1:125–32.
Mescher AL. In Susanti F, WIjaya HS, Agustina L, Agustin S,
Sadikin RE, eds. Histologi Dasar JUNQUEIRA Teks & Atlas.
th ed. Jakarta: EGC 2017:XIV.p.597–626.
Weiss E, de la Grange P, Defaye M, Lozano JJ, Aguilar F,
Hegde P, et al. Characterization of blood immune cells in
patients with decompensated cirrhosis including ACLF. Front
Immunol 2021;11:619039.
Engelmann C, Clària J, Szabo G, Bosch J, Bernardi M.
Pathophysiology of decompensated cirrhosis: portal
hypertension, circulatory dysfunction, inflammation,
metabolism and mitochondrial dysfunction. J Hepatol
;75:S49–66.
Popoiag RE, Suceveanu AI, Suceveanu AP, Micu SI, Voinea
F, Mazilu L, et al. Predictors of spontaneous bacterial
peritonitis in Romanian adults with liver cirrhosis: focus on the
neutrophil-to-lymphocyte ratio. Exp Ther Med 2021;22:983.
Article Metrics
Abstract View
: 443 times
Download : 256 times
DOI: 10.24871/2432023195
Refbacks
- There are currently no refbacks.
